Embattled Indian state looks to Bangladesh pharmas for supplies of Remdesivir
Jharkhand Chief Minister Hemant Soren has sought permission from the Indian central government to import 50,000 vials of Remdesivir from Bangladeshi pharmaceutical companies for emergency use.
He has written to D.V. Sadananda Gowda, Indian Cabinet Minister, Ministry of Chemicals and Fertilizers, requesting him to permit import and make use of the medicine.
"With the increasing demand for Remedisivir for critical patients in Jharkhand & its unavailability, we've reached out to Pharma companies in Bangladesh for buying around 50,000 vials for emergency use. I've written to DV Sadanand Gowda for permission to import as soon as possible," Chief Minister Soren tweeted.
He said they have been able to get a quotation from Beximco Pharmaceuticals Ltd for 50,000 vials of Demsivir Injection (Remdesivir) at a complete cost of US$ 1 million, which the Jharkhand government is ready to procure at the initial in light of the pressing needs of the medicine.
"I'd request you to kindly allow us to import and utilize the previously listed medicine from the said company of Bangladesh in order that we are able to save the important lives," Soren wrote in his letter to Minister Gowda.
Currently Eskayef (SK-F), Beacon, Incepta, Beximco, Healthcare and Square are making the drug, which was first produced by US biopharmaceutical company Gilead Sciences.
Remdesivir was the first drug approved by USregulator the meals and Drug Administration (FDA) for treating the SARS-CoV-2 virus. It really is indicated for treatment of COVID-19 disease in hospitalized adults and children aged 12 years and older.Full approval was preceded by the united states FDA issuing an EUA (emergency use authorization) on May 1, 2020 to permit prescribing remdesivir for serious COVID-19 (confirmed or suspected) in hospitalized adults and children, according to Medscape.
